IL17A and infection: We used anti-IL-17A or IL-17F antibody (500 μg/mouse, 20 mg/kg) or anti-TNFα antibody (250 μg/mouse, 10 mg/kg) or the respective isotype control IgG antibodies, administered weekly, starting 1 day before infection.